8.7
Excellent
376 reviews
- Communication
- 8.8
- Timeliness
- 8.9
- Accuracy
- 7.6
- Staff
- 8.8
- Value
- 8.9
Christie Cassin
8.8
- - Companion Diagnostics Development
- - 16 weeks January - May 2024
- - Pharmaceutical Company
Reviewed:
High-quality companion diagnostics development, delivered on time.
The development of companion diagnostics was of high quality, and the project was delivered on time. The team's technical expertise and understanding of the regulatory environment were key to the success of the project.
Annette Beier
6.3
- - Stability Studies
- - 16 months July 2023 - November 2024
- - Pharmaceutical Company
Reviewed:
Stability studies lacked detail, required additional validation.
The stability studies conducted were lacking in detail, and we had to perform additional validation to ensure the results were reliable. This added extra time and cost to the project. The team was responsive to feedback, but the initial work was subpar.
Shirley Kub Jr.
5.4
- - Process Development
- - 14 weeks June - September 2024
- - Biotech Company
Reviewed:
Process development project faced delays, communication issues.
The process development project encountered multiple delays, and communication was inconsistent. We had to extend our project timeline due to the setbacks, and this impacted our overall production schedule. The team was capable but seemed overextended.
Rickey Cummerata
6
- - Health Technology Assessment
- - 8 weeks July - September 2024
- - Pharmaceutical Company
Reviewed:
Health technology assessment was superficial, lacked thorough analysis.
The health technology assessment (HTA) was superficial and did not provide the level of thorough analysis we needed. Some important factors were overlooked, and we had to request additional work to cover these gaps. The overall experience was disappointing.
Richard Dicki
9.4
- - Health Technology Assessment
- - 10 weeks September - November 2023
- - Pharmaceutical Company
Reviewed:
Thorough and insightful health technology assessment.
The health technology assessment was thorough and provided valuable insights that were critical to our decision-making process. The team demonstrated a deep understanding of the health economics involved and delivered a well-rounded analysis.
